USPTO serial 87833205
Reviewed by CopyMark Law Group
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
W. Bloomfield, MI
W. Bloomfield, MI
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical products and preparations for chloasma; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical skin lotions; Pharmaceutical solutions used in dialysis; Anti-epileptic pharmaceutical preparations; Balms for pharmaceutical purposes; Collodion for pharmaceutical purposes; Dermatological pharmaceutical products; Dextrins for pharmaceutical use; Digestives for pharmaceutical purposes; Plant extracts for pharmaceutical purposes | ABANDONED | Feb 15, 2018 |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 9, 2019 | MAB4 | ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION | — |
| Jan 9, 2019 | ABN4 | ABANDONMENT - AFTER INTER PARTES DECISION | — |
| Jan 9, 2019 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Jan 9, 2019 | OP.S | OPPOSITION SUSTAINED NO. 999999 | — |
| Oct 1, 2018 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Aug 21, 2018 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jul 31, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 31, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 11, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 24, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 23, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 20, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 17, 2018 | NWAP | NEW APPLICATION ENTERED | — |